Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-11-20
1990-07-10
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514252, 514255, 544360, 544363, 544364, 544367, 544368, 544369, 544373, 544376, 544380, 544385, A61K 31495, C07D24108
Patent
active
049407090
ABSTRACT:
Diseases caused by platelet activating factor are prevented and treated by administration to a subject of a therapeutically effective amount of a piperazine compound of the formula: ##STR1## wherein R.sup.1 to R.sup.4 are as defined in the specification.
REFERENCES:
patent: 3976773 (1976-08-01), Curran
patent: 4038429 (1977-07-01), Smith et al.
patent: 4111925 (1978-09-01), Bachman
patent: 4289707 (1981-09-01), Caldwell et al.
patent: 4289759 (1981-09-01), Heavner et al.
patent: 4554102 (1985-11-01), Dong et al.
patent: 4569793 (1986-02-01), Dong et al.
patent: 4611076 (1986-09-01), Dong et al.
patent: 4694081 (1987-09-01), Miller et al.
Tran et al, Chem. Abst., 96-218218f (1982).
Hope et al, Chem. Abst., 86-16936w, "The Application of Ketimine Derivatives of Amino Acids to Peptide Synthesis".
Sumitomo Chemical Co. Ltd., JP 5913779, Chem. Abst. 100-209873q (1984).
Johne et al, Die Pharmazie, vol. 32, No. 1 (1977), pp. 1-16.
Kanmera et al, Chem. Abst. 95-7743q (1981).
Kanmera et al, Chem. Abst. 93-221027m (1980).
Hashimoto et al, Chem. Abst. 98-215972c.
Hashimoto Masashi
Hemmi Keiji
Miyazaki Yoshio
Nakaguti Osamu
Shimazaki Norihiko
Fujisawa Pharmaceutical Co. Ltd.
Shen Cecilia
LandOfFree
Piperazine compound as PAF-antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine compound as PAF-antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine compound as PAF-antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1721063